SK bioscience’s typhoid vaccine receives WHO prequalification

SK bioscience has achieved a significant milestone with its typhoid conjugate vaccine, SKYTyphoid, receiving WHO prequalification.

Feb 26, 2024 - 18:00

SK bioscience’s typhoid vaccine receives WHO prequalification

SK bioscience has achieved a significant milestone with its typhoid conjugate vaccine, SKYTyphoid, receiving WHO prequalification.

Read the original article

Tags:

Previous Article

Merck’s Keytruda regimen gains positive EMA CHMP opinion

Moderna concludes construction at new mRNA vaccine facility in Canada

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Anavex’s slow journey to failure

Anavex’s slow journey to failure

Jan 4, 2024

Life-extending epilepsy surgery performed less often in Black children, study finds

Life-extending epilepsy surgery performed less often in...

Dec 1, 2023

CD70 CAR-T by UTC Therapeutics for Follicular Lymphoma:...

Aug 10, 2023